- Home
- WHLR vs QLGN Comparison
WHLR vs QLGN Comparison
Compare WHLR & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- QLGN
- Stock Information
- Founded
- WHLR 2011
- QLGN 1996
- Country
- WHLR United States
- QLGN United States
- Employees
- WHLR N/A
- QLGN N/A
- Industry
- WHLR Real Estate Investment Trusts
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- QLGN Health Care
- Exchange
- WHLR Nasdaq
- QLGN Nasdaq
- Market Cap
- WHLR 2.8M
- QLGN 2.4M
- IPO Year
- WHLR 2012
- QLGN N/A
- Fundamental
- Price
- WHLR $3.41
- QLGN $3.41
- Analyst Decision
- WHLR
- QLGN
- Analyst Count
- WHLR 0
- QLGN 0
- Target Price
- WHLR N/A
- QLGN N/A
- AVG Volume (30 Days)
- WHLR 373.7K
- QLGN 111.5K
- Earning Date
- WHLR 05-05-2025
- QLGN 04-15-2025
- Dividend Yield
- WHLR N/A
- QLGN N/A
- EPS Growth
- WHLR N/A
- QLGN N/A
- EPS
- WHLR N/A
- QLGN N/A
- Revenue
- WHLR $104,307,000.00
- QLGN N/A
- Revenue This Year
- WHLR N/A
- QLGN N/A
- Revenue Next Year
- WHLR N/A
- QLGN N/A
- P/E Ratio
- WHLR N/A
- QLGN N/A
- Revenue Growth
- WHLR 2.26
- QLGN N/A
- 52 Week Low
- WHLR $2.92
- QLGN $2.96
- 52 Week High
- WHLR $15,552.00
- QLGN $29.45
- Technical
- Relative Strength Index (RSI)
- WHLR 20.79
- QLGN 51.52
- Support Level
- WHLR $5.20
- QLGN $3.09
- Resistance Level
- WHLR $4.50
- QLGN $3.78
- Average True Range (ATR)
- WHLR 0.74
- QLGN 0.28
- MACD
- WHLR 0.99
- QLGN 0.05
- Stochastic Oscillator
- WHLR 11.65
- QLGN 39.60
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.